Early Stage Researchers (ESRs)

IT-DED3 aims to integrate Early Stage Researchers (ESRs) with different scientific backgrounds together in a multidisciplinary platform for DED drug development.

Our twelve Early Stage Researchers (ESRs) have started between September and November 2018 and are appointed for 36 months.

    Alba Ramos Llorca      Camilla Scarpellini     Agnese Compagnone     Nikolaos Katsinas
     Davide Ceradini           Luna Krstić          Anusha Balla             ESR8
Adrián Guerrero Moreno       Bao Tran Ngoc      Md Asif Khan Setu        Maha Abdallah